GENE ONLINE|News &
Opinion
Blog

Moderna
Pharmaceutical Giants Expand Research and Manufacturing Capabilities, Fueling 2024 Innovation and Growth
2024-03-01
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
JPM 2024: AZ, Ginkgo and Moderna Provides Business Updates, Illustrating Optimistic Prospects
2024-01-11
GeneOnline’s Weekly News Highlights: Oct 30-Nov 3
2023-11-07
Moderna Launches mRNA Platform Incubator Network to Boost Australian mRNA Research
2023-11-06
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
Moderna’s Cancer Vaccine to Enter Phase 3 Trials This Year
2023-04-17
Moderna’s mRNA Flu Vaccine Development Slow Going as Data Rolls In
2023-04-11
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
A New Phase in Drug Development: Programming the Genome
2023-03-02
Moderna, Life Edit To Develop In Vivo Gene Editing Therapies
2023-02-23
Moderna Welcomes Phase 3 Win For RSV Vaccine
2023-01-18
Moderna’s Personalized Cancer Therapy: The New Transformative Approach to Oncology
2022-12-08
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
Moderna Gets $250 Million from MSD in Personal Cancer Vaccine Licensing Option
2022-10-12
1 2 3 5
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top